PCP: The Angel Dust

Phencyclidine (PCP), commonly known as "Angel Dust," is a dissociative drug that was initially developed as an anesthetic in the 1950s. However, due to its severe psychological side effects, including hallucinations and delusions, its medical use was discontinued. Today, PCP is classified as a Schedule II controlled substance due to its high potential for abuse and its dangerous effects.

Understanding PCP

PCP affects the brain by blocking NMDA receptors, which are involved in pain perception, cognition, and emotional regulation. This results in a dissociative state, causing users to feel detached from their bodies and surroundings.

Effects of PCP

PCP can induce a range of effects, depending on the dose:

Medical History and Research

Although PCP was originally developed for medical purposes, its use was abandoned due to unpredictable side effects. However, research into NMDA receptor antagonists continues, with some derivatives of PCP being studied for potential therapeutic applications in depression and neurodegenerative disorders.

Risks and Addiction

PCP is highly addictive, and prolonged use can lead to severe cognitive and behavioral issues. Chronic users may experience memory loss, depression, and persistent hallucinations. Additionally, the drug’s dissociative effects increase the risk of accidental injuries and aggressive behavior.

Legal Status

Due to its dangerous effects, PCP is illegal in most countries. Law enforcement agencies consider it a major public health threat, and its distribution is strictly regulated.

Conclusion

PCP, or Angel Dust, remains one of the most potent and dangerous dissociative drugs. While its medical use has been discontinued, ongoing research into NMDA receptor modulation may lead to new therapeutic developments. However, its potential for abuse and severe psychological effects make it a major concern for public health and law enforcement.

HOME